Keeping the M in mind: recombinant human GMCSF and Crohn's disease.
Bickston
Stephen J
SJ
Digestive Health Center of Excellence, University of Virginia, Charlottesville, Virginia, USA.
D003424:Crohn Disease / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D020714:Maximum Tolerated Dose; D010865:Pilot Projects; D011446:Prospective Studies; D012646:Self Administration; D012720:Severity of Illness Index; D016896:Treatment Outcome
D016178:Granulocyte-Macrophage Colony-Stimulating Factor